Vaxxinity, Inc. ( VAXX) - Key Metrics
VAXX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2023Q4 | $0 | -$0.09 | -$0.09 | -$0.10 |
| 2023Q3 | $0 | -$0.10 | -$0.10 | -$0.11 |
| 2023Q2 | $0 | -$0.11 | -$0.10 | -$0.10 |
| 2023Q1 | $0 | -$0.15 | -$0.16 | -$0.16 |
| 2022Q4 | $0 | -$0.16 | -$0.11 | -$0.12 |
VAXX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2023Q4 | 0% | -2.36 |
| 2023Q3 | 0% | -3.43 |
| 2023Q2 | 0% | -5.73 |
| 2023Q1 | 0% | -3.78 |
| 2022Q4 | 0% | -2.19 |
VAXX
Price: $0
52 week price:
Earnings Per Share: -0.45 USD
P/E Ratio: -0.05
Exchange: OEM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 380403
Market Capitalization: 1.3 million